Short Interest in Apollomics, Inc. (NASDAQ:APLMW) Expands By 319.7%

Apollomics, Inc. (NASDAQ:APLMW) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 151,500 shares, a growth of 319.7% from the November 15th total of 36,100 shares. Based on an average trading volume of 77,800 shares, the short-interest ratio is currently 1.9 days.

Apollomics Trading Up 6.4 %

Shares of Apollomics stock traded up $0.00 on Wednesday, hitting $0.01. The company had a trading volume of 318,020 shares, compared to its average volume of 54,740. The business has a 50-day simple moving average of $0.01 and a 200-day simple moving average of $0.01. Apollomics has a 52 week low of $0.01 and a 52 week high of $0.06.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.